Skip to NavigationSkip to content

Features

Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its biggest stories, according to our readers.

What will be the key industry trends in 2017? Here at Pharmafile, we look ahead to what we expect could be some of the major trends that will...

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’...

Dr Emma Harvey, ‎senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the field of ultra-...

Spend any time looking into patient adherence and some remarkable figures will come your way: huge losses of money, major pressure placed on...

The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics,...

Matt Fellows examines this promising research practice and how it could revamp the pharma R&D landscape.

In the second part of our clinical trials feature, Ben Hargreaves takes take a look at how social media and apps can become...

In the first part of a special double feature, Ben Hargreaves takes a look at how clinical trials are haemorrhaging money...

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending
debate on the power of drug companies to charge...